Search research articles
Contact Us
Filters
Showing results (151-160 of 272) with videos related to
Page
of 28
Sort By:
Frontiers in Immunology
|
July 8, 2024
Lrba participates in the differentiation of IgA+ B lymphocytes through TGFβR signaling
José Mizael Flores-Hermenegildo, Felipe de Jesús Hernández-Cázares, Daniela Pérez-Pérez, et al.
Cell Stem Cell
|
March 26, 2019
Neocortical Expansion Due to Increased Proliferation of Basal Progenitors Is Linked to Changes in Their Morphology
Nereo Kalebic, Carlotta Gilardi, Barbara Stepien, et al.
Neurochemistry International
|
May 22, 2017
Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease
Simone Lista, Nicola Toschi, Filippo Baldacci, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 7, 2017
Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease
Filippo Baldacci, Nicola Toschi, Simone Lista, et al.
Cancer Cell International
|
May 12, 2012
Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers
Casey M Turk, Katerina D Fagan-Solis, Kristin E Williams, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 9, 2009
A protein interaction node at the neurotransmitter release site: domains of Aczonin/Piccolo, Bassoon, CAST, and rim converge on the N-terminal domain of Munc13-1
Xiaolu Wang, Bin Hu, Agata Zieba, et al.
Journal of Alzheimer'S Disease : JAD
|
July 22, 2017
Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study
Simone Lista, Nicola Toschi, Filippo Baldacci, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 13, 2018
Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ<sub>1-42</sub>, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40
Harald Hampel, Nicola Toschi, Filippo Baldacci, et al.
Plos One
|
June 7, 2013
Robust automated detection of microstructural white matter degeneration in Alzheimer's disease using machine learning classification of multicenter DTI data
Martin Dyrba, Michael Ewers, Martin Wegrzyn, et al.
Journal of Neurology
|
December 21, 2017
Mutations outside the N-terminal part of RBCK1 may cause polyglucosan body myopathy with immunological dysfunction: expanding the genotype-phenotype spectrum
Martin Krenn, Elisabeth Salzer, Ingrid Simonitsch-Klupp, et al.
Page
of 28
Search research articles
Search
Showing results (151-160 of 272) with videos related to
Sort By:
Page
of 28
Frontiers in Immunology
|
July 8, 2024
Lrba participates in the differentiation of IgA+ B lymphocytes through TGFβR signaling
José Mizael Flores-Hermenegildo, Felipe de Jesús Hernández-Cázares, Daniela Pérez-Pérez, et al.
Cell Stem Cell
|
March 26, 2019
Neocortical Expansion Due to Increased Proliferation of Basal Progenitors Is Linked to Changes in Their Morphology
Nereo Kalebic, Carlotta Gilardi, Barbara Stepien, et al.
Neurochemistry International
|
May 22, 2017
Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease
Simone Lista, Nicola Toschi, Filippo Baldacci, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 7, 2017
Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease
Filippo Baldacci, Nicola Toschi, Simone Lista, et al.
Cancer Cell International
|
May 12, 2012
Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers
Casey M Turk, Katerina D Fagan-Solis, Kristin E Williams, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 9, 2009
A protein interaction node at the neurotransmitter release site: domains of Aczonin/Piccolo, Bassoon, CAST, and rim converge on the N-terminal domain of Munc13-1
Xiaolu Wang, Bin Hu, Agata Zieba, et al.
Journal of Alzheimer'S Disease : JAD
|
July 22, 2017
Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study
Simone Lista, Nicola Toschi, Filippo Baldacci, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 13, 2018
Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ<sub>1-42</sub>, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40
Harald Hampel, Nicola Toschi, Filippo Baldacci, et al.
Plos One
|
June 7, 2013
Robust automated detection of microstructural white matter degeneration in Alzheimer's disease using machine learning classification of multicenter DTI data
Martin Dyrba, Michael Ewers, Martin Wegrzyn, et al.
Journal of Neurology
|
December 21, 2017
Mutations outside the N-terminal part of RBCK1 may cause polyglucosan body myopathy with immunological dysfunction: expanding the genotype-phenotype spectrum
Martin Krenn, Elisabeth Salzer, Ingrid Simonitsch-Klupp, et al.
Page
of 28